Confirm the DMD-gene diagnosis rather than relying on the Becker label alone
DMD and BMD are both dystrophinopathies caused by variants in the DMD gene, but the amount and function of dystrophin and the clinical course differ. DGM describes Becker muscular dystrophy as generally milder and more slowly progressive than Duchenne because some functional dystrophin remains. A modern review should include the complete molecular report and the current phenotype.
- DMD-gene deletion/duplication result
- Sequencing result when deletion/duplication testing is negative
- Variant interpretation and predicted reading-frame effect
- Age at symptom onset and progression
- CK and previous muscle-pathology findings
- Family history of muscle disease or cardiomyopathy
BMD can be mistaken for an unspecified LGMD or hyperCKemia
Because Becker disease can present later and more mildly than Duchenne, some patients first receive labels such as limb-girdle muscular dystrophy, exercise intolerance or unexplained high CK. DMD-gene analysis and the pattern of weakness can clarify the diagnosis. In unresolved cases, specialized muscle pathology or dystrophin analysis may still be useful.
Cardiac surveillance is a central BMD priority
Cardiomyopathy and rhythm abnormalities can be important in Becker muscular dystrophy and may not parallel the degree of skeletal-muscle weakness. Charité specifically includes BMD among muscular dystrophies evaluated for cardiac involvement. A specialist plan can include ECG, echocardiography, Holter monitoring and cardiac MRI according to age, genotype, symptoms and prior findings.
Cardiac treatment should begin from findings, not from muscle symptoms
If ventricular dysfunction, fibrosis, arrhythmia or conduction disease is found, cardiology should manage it using the appropriate heart-failure or rhythm pathway. A person who still walks well can nevertheless need active cardiac treatment. Chest pain, fainting, sustained palpitations or acute breathlessness require urgent local assessment rather than travel for a routine second opinion.
Respiratory follow-up depends on disease severity
Respiratory weakness is usually less early and less severe than in classic DMD but can occur as BMD progresses. Pulmonary-function testing, cough effectiveness and sleep-related breathing assessment should be added according to symptoms and functional stage. Non-invasive ventilation or cough assistance is selected when objective respiratory impairment justifies it.
Physiotherapy aims to preserve function without excessive overuse
Rehabilitation should maintain range of motion, mobility and participation while avoiding repeated high-load eccentric muscle injury. The plan can include stretching, moderate individualized aerobic activity, contracture prevention, occupational therapy and orthotic or mobility support according to current weakness.
- Gait and stair function
- Hip and shoulder-girdle strength
- Ankle range of motion and contractures
- Falls and fatigue
- Work and daily-living adaptations
- Orthoses or mobility devices when useful
DMD drug approvals cannot be copied automatically to BMD
Some medicines discussed in Duchenne care have regulatory indications specifically written for DMD. A Becker patient should not assume that a DMD approval automatically covers BMD simply because both conditions involve the DMD gene. German centers can review any off-label question, evidence and clinical-trial eligibility, but experimental or non-indicated treatment should not be presented as established BMD therapy.
Female relatives can need genetic and cardiac counseling
Dystrophinopathies are X-linked. Female carriers may be asymptomatic, have muscle symptoms or develop cardiac involvement. Once the familial DMD-gene variant is known, human-genetics counseling can guide testing of relatives and appropriate cardiac follow-up rather than assuming carrier status has no clinical significance.
Anesthesia and surgery should account for the neuromuscular diagnosis
Orthopedic or other surgery should be planned with awareness of the dystrophinopathy, cardiac status and respiratory reserve. Send the exact diagnosis and latest cardiopulmonary results to the anesthetic team in advance rather than treating BMD as an incidental history item.
What to send for a German BMD second opinion
The most useful review combines molecular confirmation with cardiac and functional history.
- Complete DMD-gene molecular report
- Neuromuscular specialist reports and CK history
- Muscle biopsy/dystrophin report if previously performed
- ECG, echocardiography, Holter and cardiac MRI reports when available
- Pulmonary-function or sleep-study results
- Physiotherapy, orthotic and mobility assessments
- Current medications including cardiac drugs
- Family history and carrier-testing information
- A specific question: confirm BMD, cardiac surveillance, rehabilitation, respiratory review, genetics or trial eligibility
Official sources
Sources last checked 2026-09-01. Clinical pathways, eligibility and hospital procedures can change; confirm current requirements directly with the treating center.
- Duchenne and Becker muscular dystrophies — German Society for Muscular Diseases (DGM) ↗
- DMD/BMD diagnosis group — German Society for Muscular Diseases (DGM) ↗
- Heidelberg DMD/BMD molecular genetics — Heidelberg University Hospital ↗
- Freiburg Neuromuscular Center — University Medical Center Freiburg ↗
- Charité pediatric neuromuscular diseases — Charité – Universitätsmedizin Berlin ↗
- Charité cardiology – muscular dystrophies including BMD — Charité – Universitätsmedizin Berlin ↗